Anika Therapeutics

(NASDAQ) ANIK

Current Price$14.72

Market Cap$204.11M

Since IPO (1993)+338%

5 Year-65%

1 Year+36%

1 Month+0%

Anika Therapeutics Financials at a Glance

Market Cap

$204.11M

Revenue (TTM)

$116.26M

Net Income (TTM)

$11.06M

EPS (TTM)

$-0.79

P/E Ratio

-19.38

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$14.72

Volume

Open

$14.71

Price

$14.72

Volume

Open

$14.71

Previous Close

$15.34

Daily Range

$14.70 - $14.86

52-Week Range

$7.87 - $16.24

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$14.72

Volume

Open

$14.71

Previous Close

$15.34

Daily Range

$14.70 - $14.86

52-Week Range

$7.87 - $16.24

ANIK News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anika Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

235

CEO

Stephen D. Griffin, MBA

Website

www.anika.com

Headquarters

Bedford, MA 01730, US

ANIK Financials

Key Financial Metrics (TTM)

Gross Margin

59%

Operating Margin

-11%

Net Income Margin

-10%

Return on Equity

-8%

Return on Capital

-8%

Return on Assets

-6%

Earnings Yield

-5.16%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$204.11M

Shares Outstanding

13.31M

Volume

Avg. Volume

134.51K

Financials (TTM)

Gross Profit

$63.81M

Operating Income

$11.05M

EBITDA

$5.32M

Operating Cash Flow

$11.19M

Capital Expenditure

$6.83M

Free Cash Flow

$4.36M

Cash & ST Invst.

$57.48M

Total Debt

$24.20M

Anika Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$29.61M

+13.2%

Gross Profit

$19.00M

+29.4%

Gross Margin

64.15%

N/A

Market Cap

$204.11M

N/A

Market Cap/Employee

$708.71K

N/A

Employees

288

N/A

Net Income

$5.06M

-3.8%

EBITDA

$4.08M

-51.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$15.28M

-45.3%

Accounts Receivable

$25.77M

+17.2%

Inventory

$22.84M

+7.0%

Long Term Debt

$23.79M

+1.0%

Short Term Debt

$1.94M

+3.6%

Return on Assets

-6.17%

N/A

Return on Invested Capital

-7.74%

N/A

Free Cash Flow

$6.28M

-112.5%

Operating Cash Flow

$4.85M

-3627.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

APYXApyx Medical Corporation

APYXApyx Medical Corporation$4.36-0.11%

AVRAnteris Technologies Global Corp.

AVRAnteris Technologies Global Corp.$7.32+0.92%

MXCTMaxCyte, Inc.

MXCTMaxCyte, Inc.$1.03-5.05%

LUCDLucid Diagnostics Inc.

LUCDLucid Diagnostics Inc.$0.99-2.74%

OWLTOwlet, Inc.

OWLTOwlet, Inc.$5.61+3.80%

RPIDRapid Micro Biosystems, Inc.

RPIDRapid Micro Biosystems, Inc.$2.19-5.60%

ANIXAnixa Biosciences, Inc.

ANIXAnixa Biosciences, Inc.$2.79-3.46%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

POETPoet Technologies

POETPoet Technologies$18.89-0.08%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.57-0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.09-0.04%

SLESuper League Enterprise

SLESuper League Enterprise$5.65+0.39%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.59+0.04%

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF$8.47-0.12%

PIIIP3 Health Partners

PIIIP3 Health Partners$8.24+1.04%

Questions About ANIK

What is the current price of Anika Therapeutics?

Anika Therapeutics is trading at $14.72 per share.

What is the 52-week range for Anika Therapeutics?

Over the past 52 weeks, Anika Therapeutics has traded between $7.87 and $16.24.

How much debt does Anika Therapeutics have?

As of the most recent reporting period, Anika Therapeutics reported total debt of $25.74M.

How much cash does Anika Therapeutics have on hand?

Anika Therapeutics reported $41.02M in cash and cash equivalents in its most recent financial results.

What is Anika Therapeutics’s dividend yield?

Anika Therapeutics does not currently have a dividend yield.

Anika Therapeutics

Anika Therapeutics Financials at a Glance

ANIK News

Anika (ANIK) Q2 Revenue Beats by 4%

Anika Therapeutics Beats Revenue and Earnings Estimates

Why Anika Therapeutics Stock Crushed It Today

Anika Therapeutics Blows Past Q2 Earnings Estimates

Why Pivotal Software, Anika Therapeutics, and Oracle Slumped Today

Why Anika Therapeutics, Inc. Stock Is Sinking

3 Biotech Stocks to Buy in May

3 Biotech Stocks to Buy in December

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Anika Therapeutics

ANIK Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Anika Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ANIK

What is the current price of Anika Therapeutics?

What is the 52-week range for Anika Therapeutics?

How much debt does Anika Therapeutics have?

How much cash does Anika Therapeutics have on hand?

What is Anika Therapeutics’s dividend yield?

Premium Investing Services